Skip Navigation

VAERS Bibliography - April 2004

  1. Progress Toward Poliomyelitis Eradication--India, 2003. MMWR Morb.Mortal.Wkly.Rep.  53 (11): 238-241; March 26, 2004.

  2. School-Associated Pertussis Outbreak--Yavapai County, Arizona, September 2002-February 2003. MMWR Morb.Mortal.Wkly.Rep.  53 (10): 216-219; March, 2004.

  3. HHS-CDC NEWS: Update: Adverse Events Following Civilian Smallpox Vaccination--US, 2003. Ann.Pharmacother.  38 (4): 739; April, 2004.

  4. Andersen, T.  [Influenza Vaccination--One More Time]. Ugeskr.Laeger.  166 (7): 611-612; February 9, 2004.

  5. Bender, A.; Jager, G.; Scheuerer, W.; Feddersen, B.; Kaiser, R.; Pfister, H. W.  Two Severe Cases of Tick-Borne Encephalitis Despite Complete Active Vaccination-the Significance of Neutralizing Antibodies. J.Neurol.  251 (3): 353-354; March, 2004.

  6. Bozza, S.; Montagnoli, C.; Gaziano, R.; Rossi, G.; Nkwanyuo, G.; Bellocchio, S.; Romani, L.  Dendritic Cell-Based Vaccination Against Opportunistic Fungi. Vaccine.  22 (7): 857-864; February 17, 2004.

  7. Brinkman, D. M.; Jol-van der Zijde, C. M.; ten Dam, M. M.; Vossen, J. M.; Osterhaus, A. D.; Kroon, F. P.; van Tol, M. J.  Vaccination With Rabies to Study the Humoral and Cellular Immune Response to a T-Cell Dependent Neoantigen in Man. J.Clin.Immunol.  23 (6): 528-538; November, 2003.

  8. Buff, A. M.; Welch, F. J.; Tapia, R. A.  A Review of Varicella Vaccine and Louisiana Vaccination Requirements. J.La State Med.Soc.  156 (1): 50-55; January, 2004.

  9. Butler, D.  Nigerian States Disrupt Campaign to Eradicate Polio. Nature.  428 (6979): 109; March 11, 2004.

  10. Butler, J. R.; McIntyre, P.; MacIntyre, C. R.; Gilmour, R.; Howarth, A. L.; Sander, B.  The Cost-Effectiveness of Pneumococcal Conjugate Vaccination in Australia. Vaccine.  22 (9-10): 1138-1149; March 12, 2004.

  11. Clemetson, C. A.  Elevated Blood Histamine Caused by Vaccinations and Vitamin C Deficiency May Mimic the Shaken Baby Syndrome. Med.Hypotheses.  62 (4): 533-536; 2004.

  12. Clemetson, C. A.  Individual Reactions Following Vaccinations or Inoculations Are Highly Variable. Mil.Med.  169 (2): v; February, 2004.

  13. Crittenton, E.; Davis, A.; Hoffmann, K. K.; Rutala, W. A.; Weber, D. J.  Semipermeable Dressing Used to Cover Smallpox Vaccination Sites As a Cause of Skin Damage. Infect.Control Hosp.Epidemiol.  25 (2): 96; February, 2004.

  14. Cunha, S. C.; Dourado, I.  MMR Mass Vaccination Campaigns, Vaccine-Related Adverse Events, and the Limits of the Decision Making Process, in Brazil. Health Policy.  67 (3): 323-328; March, 2004.

  15. Deng, Y.; Jing, Y.; Campbell, A. E.; Gravenstein, S.   Age-Related Impaired Type 1 T Cell Responses to Influenza: Reduced Activation Ex Vivo, Decreased Expansion in CTL Culture in Vitro, and Blunted Response to Influenza Vaccination in Vivo in the Elderly. J.Immunol.  172 (6): 3437-3446; March 15, 2004.

  16. Evans, C. T.; Legro, M. W.; Weaver, F. M.; Goldstein, B.  Influenza Vaccination Among Veterans With Spinal Cord Injury: Part 1. A Survey of Attitudes and Behavior. J.Spinal Cord.Med.  26 (3): 204-209; 2003.

  17. Farrington, C. P.  Re: "Risk Analysis of Aseptic Meningitis After Measles-Mumps-Rubella Vaccination in Korean Children by Using a Case-Crossover Design". Am.J.Epidemiol.  159 (7): 717-718; April 1, 2004.

  18. Filippis, A. M.; Nogueira, R. M.; Jabor, A. V.; Schatzmayr, H. G.; Oliveira, J. C.; Dinis, S. C.; Galler, R.  Isolation and Characterization of Wild Type Yellow Fever Virus in Cases Temporally Associated With 17DD Vaccination During an Outbreak of Yellow Fever in Brazil. Vaccine.  22 (9-10): 1073-1078; March 12, 2004.

  19. Fleck, F.  Nigerian President Holds Key to Global Polio Eradication. BMJ.  328 (7439): 544; March 6, 2004.

  20. Goldstein, B.; Hammond, M. C.  The Importance of Influenza Vaccinations in Persons With Spinal Cord Injury and Disease. J.Spinal Cord.Med.  26 (3): 219-220; 2003.

  21. Greenberg, R. N.; Schosser, R. H.; Plummer, E. A.; Roberts, S. E.; Caldwell, M. A.; Hargis, D. L.; Rudy, D. W.; Evans, M. E.; Hopkins, R. J.  Urticaria, Exanthems, and Other Benign Dermatologic Reactions to Smallpox Vaccination in Adults. Clin.Infect.Dis.  38 (7): 958-965; April 1, 2004.

  22. Gunn, S. W.  Vaccination. World J.Surg.  March 17, 2004. [Epub ahead of print].

  23. 23. Hamilton, M.; Corwin, P.; Gower, S.; Rogers, S.  Why Do Parents Choose Not to Immunise Their Children? N.Z.Med.J.  117 (1189): U768; February, 2004.

  24. Husain, S.; Slobodkin, D.; Weinstein, R. A.  Corrections to Table. Arch.Intern.Med.  164 (5): 573; March 8, 2004.

  25. Ivers, L. C.; Ryan, E. T.  Vaccination Strategies. Clin.Occup.Environ.Med.  4 (1): 27-43; February, 2004.

  26. Jack, S.  Review: Existing Epidemiological Evidence Does Not Show an Association Between Mumps, Measles, and Rubella Vaccination and Autism. Evid.Based.Nurs.  7 (1): 25; January, 2004.

  27. Jelleyman, T.; Ure, A.  Attitudes to Immunisation: a Survey of Health Professionals in the Rotorua District. N.Z.Med.J.  117 (1189): U769; February, 2004.

  28. John, T. J.  The Golden Jubilee of Vaccination Against Poliomyelitis. Indian J.Med.Res.  119:1-17; January, 2004.

  29. Kaplan, S. L.; Mason, E. O., Jr.; Wald, E. R.; Schutze, G. E.; Bradley, J. S.; Tan, T. Q.; Hoffman, J. A.; Givner, L. B.; Yogev, R.; Barson, W. J.  Decrease of Invasive Pneumococcal Infections in Children Among 8 Children's Hospitals in the United States After the Introduction of the 7-Valent Pneumococcal Conjugate Vaccine. Pediatrics.  113 (3 Pt 1): 443-449; March, 2004.

  30. Kapp, C.  Nigerian States Again Boycott Polio-Vaccination Drive. Muslim Officials Have Rejected Assurances That the Polio Vaccine Is Safe--Leaving Africa on the Brink of Reinfection. Lancet.  363 (9410): 709; February 28, 2004.

  31. Kelly, C. D.; Egan, C.; Davis, S. W.; Samsonoff, W. A.; Musser, K. A.; Drabkin, P.; Miller, J. R.; Taylor, J.; Cirino, N. M.  Laboratory Confirmation of Generalized Vaccinia Following Smallpox Vaccination. J.Clin.Microbiol.  42 (3): 1373-1375; March, 2004.

  32. Korczowski, B.  Procalcitonin and C-Reactive Protein in Vaccination-Associated Adverse Reactions. Pediatr.Infect.Dis.J.  23 (3): 283; March, 2004.

  33. LeBaron, C. W.; Starnes, D. M.; Rask, K. J.  The Impact of Reminder-Recall Interventions on Low Vaccination Coverage in an Inner-City Population. Arch.Pediatr.Adolesc.Med.  158 (3): 255-261; March, 2004.

  34. Madjid, M.; Casscells, W.  Influenza As a Bioterror Threat: the Need for Global Vaccination. Expert.Opin.Biol.Ther.  4 (3): 265-267; March, 2004.

  35. Mahan, C. M.; Kang, H. K.; Dalager, N. A.; Heller, J. M.  Anthrax Vaccination and Self-Reported Symptoms, Functional Status, and Medical Conditions in the National Health Survey of Gulf War Era Veterans and Their Families. Ann.Epidemiol.  14 (2): 81-88; February, 2004.

  36. Maitra, A.; Sherriff, A.; Griffiths, M.; Henderson, J.; Avon Longitudinal Study Of Parents And Children Study Team  Pertussis Vaccination in Infancy and Asthma or Allergy in Later Childhood: Birth Cohort Study. BMJ.  March, 2004. [Epub ahead of print].

  37. Manthey, D. E.; Stopyra, J.; Askew, K.  Referral of Emergency Department Patients for Pneumococcal Vaccination. Acad.Emerg.Med.  11 (3): 271-275; March, 2004.

  38. 38. May, T.; Silverman, R. D.; Aulisio, M. P.  Do Healthcare Professionals Have an Obligation to Be Vaccinated Against Smallpox? APA.Newsl.Philos.Med.  2 (2): 209-212; 2003.

  39. 39. Miller, G. E.; Cohen, S.; Pressman, S.; Barkin, A.; Rabin, B. S.; Treanor, J. J.  Psychological Stress and Antibody Response to Influenza Vaccination: When Is the Critical Period for Stress, and How Does It Get Inside the Body? Psychosom.Med.  66 (2): 215-223; March, 2004.

  40. Millett, P. D.  Proliferation of Biological Weapons: Challenges and Responses. Med.Confl.Surviv.  20 (1): 4-18; January, 2004.

  41. Pasquarella, A.; Perria, C.; D'Amato, M.; Billi, P.; Marceca, M.; Volpe, E.; Guasticchi, G.  [Management of Vaccination Practices in Adults: the Influenza Vaccination Campaign in Lazio Region, Italy]. Ann.Ig.  15 (6): 871-879; November, 2003.

  42. Paul, Y.  Setback in Polio Eradication in India in 2002: Reasons and Remedies. Indian Pediatr.  41 (2): 202-203; February, 2004.

  43. Petrie, K. J.; Moss-Morris, R.; Grey, C.; Shaw, M.  The Relationship of Negative Affect and Perceived Sensitivity to Symptom Reporting Following Vaccination. Br.J.Health Psychol.  9 (Pt 1): 101-111; February, 2004.

  44. Pierrynowski-Gallant, D. M.; Vollman, A. R.  Influenza Vaccination Choices. Can.Nurse.  100 (2): 16-21; February, 2004.

  45. Puvacic, S.; Mulaomerovic, M.; Karakas, S.; Tandir, S.; Nada, E.  [Expected Incidence of Post-Vaccination Complications in Vaccination Programs]. Med.Arh.  57 (5-6): 269-272; 2003.

  46. 46. Pywell, S.  Vaccination and Other Altruistic Medical Treatments: Should Autonomy or Communitarianism Prevail? Med.Law Int.  4 (3-4): 223-243; 2000.

  47. Schwartz, M.  Protective Autoimmunity and Prospects for Therapeutic Vaccination Against Self-Perpetuating Neurodegeneration. Ernst.Schering.Res.Found.Workshop.47): 133-154; 2004.

  48. Sharma, M. K.; Bhatia, V.; Swami, H. M.  Outbreak of Measles Amongst Vaccinated Children in a Slum of Chandigarh. Indian J.Med.Sci.  58 (2): 47-53; February, 2004.

  49. Shetty, P.  Weapons of Mass Vaccination. Lancet Infect.Dis.  4 (3): 129; March, 2004.

  50. Stuck, B.  [Vaccination Complacency. How to Overcome Your Patient's Skepticism and Strengthen His Motivation]. MMW.Fortschr.Med.  145 (45): 25; November 6, 2003.

  51. Tam, T.; Langley, J.  An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: Statement on Influenza Vaccination for the 2003-04 Season. Can.Commun.Dis.Rep.  30:1-5; March 1, 2004.

  52. Tugwell, B. D.; Lee, L. E.; Gillette, H.; Lorber, E. M.; Hedberg, K.; Cieslak, P. R.  Chickenpox Outbreak in a Highly Vaccinated School Population. Pediatrics.  113 (3 Pt 1): 455-459; March, 2004.

  53. Turner, N.  Concerns of Health Providers and Parents Affect Immunisation Coverage. N.Z.Med.J.  117 (1189): U766; February, 2004.

  54. Utz, S.; Richard, J. L.; Capaul, S.; Matter, H. C.; Hrisoho, M. G.; Muhlemann, K.  Phylogenetic Analysis of Clinical Mumps Virus Isolates From Vaccinated and Non-Vaccinated Patients With Mumps During an Outbreak, Switzerland 1998-2000. J.Med.Virol.  73 (1): 91-96; May, 2004.

  55. van Neerven, R. J.; Arvidsson, M.; Ipsen, H.; Sparholt, S. H.; Rak, S.; Wurtzen, P. A.  A Double-Blind, Placebo-Controlled Birch Allergy Vaccination Study: Inhibition of CD23-Mediated Serum-Immunoglobulin E-Facilitated Allergen Presentation. Clin.Exp.Allergy.  34 (3): 420-428; March, 2004.

  56. Vincents, G.  [Influenza Vaccination]. Ugeskr.Laeger.  166 (7): 612; February 9, 2004.

  57. Walker, R. I.; Blanchard, T.; Braun, J. M.; Cebra, J. J.; Cross, A. S.; Fattom, A.; Giannasca, P. J.; Holder, I. A.; Huebner, J.; Matthews, R.; Pier, G. B.; Romani, L.; von Specht, B. U.; Trautmann, M.  Meeting Summary: Possibilities for Active and Passive Vaccination Against Opportunistic Infections. Vaccine.  22 (7): 801-804; February 17, 2004.

  58. Way, A. B.  Choices About Meningococcal Vaccination. N.Engl.J.Med.  350 (11): 1156; March 11, 2004.

  59. Weaver, F. M.; Goldstein, B.; Evans, C. T.; Legro, M. W.; LaVela, S.; Smith, B.; Miskevics, S.; Hammond, M. C.  Influenza Vaccination Among Veterans With Spinal Cord Injury: Part 2. Increasing Vaccination Rates. J.Spinal Cord.Med.  26 (3): 210-218; 2003.

  60. Wright, S. A.; Taggart, A. J.  Pneumococcal Vaccination for RA Patients on TNF-{Alpha} Antagonists. Rheumatology.(Oxford).  43 (4): 523; April, 2004.

  61. Young, D. C.  Smallpox Vaccination in the Shadow of Jenner. Lancet.  363 (9410): 738; February 28, 2004.

  62. Zangwill, K. M.; Belshe, R. B.  Safety and Efficacy of Trivalent Inactivated Influenza Vaccine in Young Children: a Summary for the New Era of Routine Vaccination. Pediatr.Infect.Dis.J.  23 (3): 189-197; March, 2004.

[Top]